SGHT

4.04

4.94% 0.19

Dopo l'orario di chiusura: 4.04

Sight Sciences Inc (SGHT)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché SGHT Giù? Forum Previsione

Precedente Chiudi:

$3.85

Aprire:

$3.9

Volume 24 ore:

279.20K

Relative Volume:

0.85

Capitalizzazione di mercato:

$218.18M

Reddito:

$77.36M

Utile/perdita netta:

$-38.43M

Rapporto P/E:

-5.4536

EPS:

-0.7408

Flusso di cassa netto:

$-29.92M

1 W Prestazione:

+9.49%

1M Prestazione:

-22.01%

6M Prestazione:

+17.78%

1 anno Prestazione:

+50.19%

Intervallo 1D:

$3.89

$4.11

Intervallo di 1 settimana:

$3.41

$4.11

Portata 52W:

$2.03

$9.2362

Sight Sciences Inc Stock (SGHT) Company Profile

Nome

Sight Sciences Inc

Settore

Healthcare (1114)

Industria

Medical Devices (143)

Telefono

(415) 889-0550

Indirizzo

4040 CAMPBELL AVE,, MENLO PARK

Dipendente

186

Cinguettio

Prossima data di guadagno

2025-03-05

Ultimi documenti SEC

SGHT's Discussions on Twitter

Compare SGHT vs ABT, SYK, MDT, BSX, EW

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
SGHT Sight Sciences Inc	4.04	207.92M	77.36M	-38.43M	-29.92M	-0.7408
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-01-05	Aggiornamento	Piper Sandler	Neutral → Overweight
2025-08-08	Aggiornamento	Lake Street	Hold → Buy
2024-12-06	Iniziato	UBS	Buy
2024-11-04	Downgrade	Lake Street	Buy → Hold
2024-08-21	Iniziato	Lake Street	Buy
2023-09-12	Downgrade	BofA Securities	Neutral → Underperform
2023-09-12	Downgrade	Piper Sandler	Overweight → Neutral
2023-09-12	Downgrade	William Blair	Outperform → Mkt Perform
2023-08-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2023-07-10	Downgrade	Citigroup	Buy → Neutral
2023-01-06	Aggiornamento	Stifel	Hold → Buy
2022-10-04	Iniziato	Needham	Hold
2022-07-26	Iniziato	Stifel	Hold
2022-02-03	Iniziato	William Blair	Outperform
2022-01-07	Aggiornamento	Morgan Stanley	Equal-Weight → Overweight

Mostra tutto

Sight Sciences Inc Borsa (SGHT) Ultime notizie

Mar 25, 2026

Aug Ideas: Is Sight Sciences Inc in a consolidation phase2026 Highlights & High Accuracy Investment Signals - baoquankhu1.vn

Mar 25, 2026

Mar 24, 2026

Sight Sciences Inc stock faces pressure amid weak Q4 guidance and slowing growth in eye care devices - AD HOC NEWS

Mar 24, 2026

Mar 18, 2026

Citigroup maintains Sight Sciences (SGHT) neutral recommendation - MSN

Mar 18, 2026

Sight Sciences outlines $82M–$88M 2026 revenue target while expanding interventional dry eye strategy - MSN

Mar 18, 2026

Mar 17, 2026

Can Sight Sciences Inc weather a recession2026 Technical Overview & Weekly High Conviction Trade Ideas - baoquankhu1.vn

Mar 17, 2026

Mar 16, 2026

Earnings call transcript: Sight Sciences beats Q4 2025 forecasts, stock rises - Investing.com Nigeria

Mar 16, 2026

Mar 14, 2026

Prosight Management LP Sells 431,746 Shares of Sight Sciences, Inc. $SGHT - MarketBeat

Mar 14, 2026

Mar 12, 2026

Morgan Stanley Sticks to Its Hold Rating for Sight Sciences (SGHT) - The Globe and Mail

Mar 12, 2026

Mar 11, 2026

Stock Report: Can Sight Sciences Inc weather a recession2025 Volume Leaders & Low Volatility Stock Suggestions - baoquankhu1.vn

Mar 07, 2026

Mar 06, 2026